CE marked, FDA cleared, NMPA approved

High Generalization Ability and Rigorous Clinical Validation.

Efficient Analysis and High Sensitivity: effective for small nodules, improving efficiency and accuracy.

Intelligent Follow-up and Treatment Efficacy Evaluations: auto-analysis based on relevant priors to compare nodule development and improve treatment outcomes.

Intelligent Case Database: search for similar cases in the database, providing an intelligent reference for clinical decision making.

Structured Reporting: automatic report generation in accordance with professional guidelines.